Research notes from the team at DAAVY Research

Understanding research peptides, one plain-language note at a time.

Compound Brief breaks down sourcing, testing, documentation, and storage for laboratory researchers — what the paperwork actually means and what to check before you trust it.

Published by the team behind DAAVY Research, a research-peptide supplier. Where an article mentions DAAVY, it says so.

Recent articles

Data

6,285 Peptide Test Reports: What the Largest Public Dataset Shows

A preprint analyzed 6,285 third-party test reports on research peptides: 41.6% to 71.1% failed basic criteria, depending on the cutoff. What it can and cannot show.

8 min read
Regulatory news

What the HHS Peptide Notice Actually Says (and Doesn't)

The Federal Register notice is two pages. What it says, what sits in the appendices, the docket number and the comment window.

5 min read
Tool

COA Bench: Free Peptide COA Tools

Move the purity and content numbers, quiz yourself on what each report line answers, and check a report against two published cutoffs.

Interactive
Documentation

A BPC-157 Certificate of Analysis, Line by Line

Every field on a real BPC-157 10 mg COA explained: dates, lot number, LC-MS/MS identity, content, HPLC purity, and what the report leaves out.

8 min read
Regulatory

HHS Interim Policy on Six Peptides: What the Document Says

On Oct 28, 2026 HHS announced temporary enforcement discretion for compounding six peptides. What the policy document requires, what it leaves open, and why.

7 min read

See all articles →

About Compound Brief

Compound Brief is a free resource for laboratory researchers working with research peptides and compounds, published by the team behind DAAVY Research, a Texas-based supplier of research peptides. We write plain-language explainers on documentation, testing methods, and handling — the kind of thing that's usually buried in a PDF or a forum thread. Compound Brief is DAAVY Research's education site. DAAVY sells research peptides; some articles link to its pages. When an article mentions DAAVY, we say it's our own company.